+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United Kingdom Renal Denervation Market, By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product, By Therapeutic Area, By End User, By Region, Competition Forecast & Opportunities, 2027

  • PDF Icon

    Report

  • 78 Pages
  • July 2022
  • Region: United Kingdom
  • TechSci Research
  • ID: 5624438
Free Webex Call
10% Free customization

United Kingdom renal denervation market may flourish with an impressive CAGR during the forecast period of 2023-2027, on the backbone of increasing number of patients suffering from hypertension

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

United Kingdom renal denervation market may flourish with an impressive CAGR during the forecast period of 2023-2027, on the backbone of increasing number of patients suffering from hypertension. Rising instances of high blood pressure among the population drives the growth of the United Kingdom renal denervation market in the upcoming five years. Growing instances of therapy resistant hypertension may also be considered as a key growth factor for the United Kingdom renal denervation market in the next five years. The population in the United kingdom is highly inclined towards consumption of junk food and fast food. Online delivery of the food & groceries adds to the convenience of the working class population living a highly sedentary lifestyle. Growing instances of younger population being involved with heavy alcohol consumption and smoking also fuels the growing risks of high blood pressure thereby aiding the growth of the United Kingdom renal denervation market in the future five years.

The United Kingdom renal denervation market is segmented by technology, product, therapeutic area, end user, competitional landscape, and regional distribution. Based on technology, the market is further segmented into ultrasound ablation, radiofrequency ablation, pharmacologic ablation, and micro-infusion. Radiofrequency ablation is anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years due to its advantages like safety of the procedure and time efficiency. Also, ultrasound ablation is expected to register significant growth in the next five years due to the high-frequency sound waves that ablates the nerves without getting in direct contact with the tissues, thus reducing injuries to the renal arteries.

By product, the market is fragmented into catheters, single electrode catheter, multi electrode catheter, RF generator, and others. Catheters are anticipated to lead the market segment and hold the largest revenue shares of the market in the upcoming five years on the grounds of traditional use of the medical devices. RF generators may register fastest growing CAGR in the next five years due to radiofrequency ablation being the most preferred method for the treatment.

Medtronic United Kingdom, Boston Scientific Limited, Abbott Laboratories Limited, CardioSonic Limited, Terumo UK Limited, Johnson & Johnson Limited, among others is a partial list of major market players responsible for the growth of United Kingdom renal denervation market.

Years considered for this report:

Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of the United Kingdom Renal Denervation market from 2017 to 2021.
  • To estimate and forecast the market size of United Kingdom Renal Denervation Market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast the United Kingdom Renal Denervation Market based on Technology, Product, Therapeutic Area, End User, Region, and Company.
  • To identify the dominant region or segment in the United Kingdom Renal Denervation Market.
  • To identify drivers and challenges for the United Kingdom Renal Denervation Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the United Kingdom Renal Denervation Market.
  • To identify and analyze the profiles of leading players operating in the United Kingdom Renal Denervation Market.
  • To identify key sustainable strategies adopted by market players inUnited Kingdom Renal Denervation Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies, which could not be identified due to the limitations of secondary research. The publisher analyzed the companies and presence of all major players across the country.

The publisher calculated the market size of the United Kingdom Renal Denervation Market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.

Key Target Audience:

  • Renal Denervation companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to renal denervation

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:


In this report, United Kingdom renal denervation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

United Kingdom Renal Denervation Market, By Technology:

  • Ultrasound Ablation
  • Radiofrequency Ablation
  • Pharmacologic Ablation
  • Micro-infusion

United Kingdom Renal Denervation Market, By Product:

  • Catheters
  • Single Electrode Catheter
  • Multi Electrode Catheter
  • RF Generator
  • Others

United Kingdom Renal Denervation Market, By Therapeutic Area:

  • Hypertension
  • Heart Failure
  • Diabetes
  • Renal Failure
  • Others

United Kingdom Renal Denervation Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

United Kingdom Renal Denervation Market, By Region:

  • London
  • East Anglia
  • Southwest
  • Southeast
  • Scotland
  • East Midlands
  • Yorkshire & Humberside

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom renal denervation market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on United Kingdom Renal Denervation Market5. Voice of Customer
6. United Kingdom Renal Denervation Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion)
6.2.2. By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others)
6.2.3. By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Market Map
7. London Renal Denervation Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Product
7.2.3. By Therapeutic Area
7.2.4. By End User
8. East Anglia Renal Denervation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Product
8.2.3. By Therapeutic Area
8.2.4. By End User
9. Southwest Renal Denervation Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Product
9.2.3. By Therapeutic Area
9.2.4. By End User
10. Southeast Renal Denervation Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Product
10.2.3. By Therapeutic Area
10.2.4. By End User
11. Scotland Renal Denervation Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Technology
11.2.2. By Product
11.2.3. By Therapeutic Area
11.2.4. By End User
12. East Midlands Renal Denervation Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Technology
12.2.2. By Product
12.2.3. By Therapeutic Area
12.2.4. By End User
13. Yorkshire & Humberside Renal Denervation Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Technology
13.2.2. By Product
13.2.3. By Therapeutic Area
13.2.4. By End User
14. Market Dynamics
14.1. Drivers
14.2. Challenges
15. Market Trends & Developments16. Policy & Regulatory Landscape17. United Kingdom Economic Profile
18. Competitive Landscape
18.1. Medtronic United Kingdom
18.2. Boston Scientific Limited
18.3. Abbott Laboratories Limited
18.4. CardioSonic Limited
18.5. Terumo UK Limited
18.6. Johnson & Johnson Limited
19. Strategic Recommendations
(Note: The companies list can be customized based on the client requirements.)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic United Kingdom
  • Boston Scientific Limited
  • Abbott Laboratories Limited
  • CardioSonic Limited
  • Terumo UK Limited
  • Johnson & Johnson Limited